Novel Micro/Nanomaterials Based Drug Delivery Systems for Theranostic Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 120
Special Issue Editors
2. Institute for Bioengineering and Biosciences (iBB), Instituto Superior Técnico, University of Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal
Interests: the development of new drug delivery systems by means of colloidal carriers; the structural characterization of proteins entrapped into micro- and nanocarriers; the lyophilization of biopharmaceuticals; the targeted and controlled delivery of drugs across biological barriers; the solid-state characterization of pharmaceuticals and the drying of pharmaceuticals and biopharmaceuticals; regenerative medicine
Special Issues, Collections and Topics in MDPI journals
2. iBB–Institute for Bioengineering and Biosciences and Associate Laboratory i4HB—Institute for Health and Bioeconomy, Instituto Superior Técnico, University of Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal
3. CQC-IMS, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal
Interests: drug delivery; drug discovery; medicinal chemistry; biomaterials; sustainability; multicomponent reactions
Special Issues, Collections and Topics in MDPI journals
Interests: nanotechnology; drug delivery systems; regenerative medicine; synthetic biology; genome editing; lactic acid bacteria
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite and welcome submissions to our upcoming Special Issue, titled "Novel Micro/Nanomaterial-Based Drug Delivery Systems for Theranostic Applications". This Special Issue aims to explore cutting-edge developments in the field of micro- and nanomaterials, particularly focusing on their applications in drug delivery systems for theranostics. The convergence of nanotechnology and medicine has opened up new frontiers in healthcare, enabling the development of highly efficient drug delivery systems with the ability to simultaneously diagnose and treat diseases. The use of micro- and nanomaterials in drug delivery not only enhances the effectiveness of therapeutic agents but also minimizes side effects, thereby revolutionizing the approach to disease management. This research area holds significant promise for advancing personalized medicine, developing targeted therapies, and improving the real-time monitoring of treatment responses, making it a vital field of study in modern medical science.
The aim of this Special Issue is to present groundbreaking research on micro- and nanomaterial-based drug delivery systems used for theranostic applications. It aligns with the journal's focus on pharmaceutics and biopharmaceutics, and it seeks to compile a collection of at least 10 high-quality articles. The Special Issue aims to provide a platform for interdisciplinary research contributions.
In this Special Issue, original research articles and reviews are welcome. Potential research areas include (but are not limited to) the following:
- The design and synthesis of novel micro- and nanomaterials for drug delivery;
- Nanocarriers used for targeted drug delivery and controlled release;
- Biocompatibility and toxicity studies of micro/nanomaterials;
- Nanotechnology in imaging and diagnostics for theranostic applications;
- Clinical translational studies of nanomaterial-based theranostics;
- Advances in personalized medicine using micro/nanotechnology;
- Innovations in drug delivery systems for specific diseases (e.g., cancer, cardiovascular diseases);
- Multifunctional and stimuli-responsive drug delivery platforms.
We look forward to receiving your contributions.
Dr. Pedro Fonte
Dr. Pedro Brandão
Dr. Sofia de Oliveira Dias Duarte
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- drug delivery systems
- theranostics
- micro/nanomaterials
- personalized medicine
- nanomedicine
- cancer
- diagnosis
